About Vessix Vascular
Vessix Vascular is a company based in Laguna Hills (United States) founded in 2003 was acquired by Boston Scientific in November 2012.. Vessix Vascular has raised $27.7 million across 2 funding rounds from investors including Boston Scientific, Orbimed and Rothschild. The company has 10 employees as of December 31, 2021. Vessix Vascular operates in a competitive market with competitors including ReCor Medical, Ablative Solutions, Brattea, Kona Medical and Autonomix, among others.
- Headquarter Laguna Hills, United States
- Employees 10 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vessix Vascular Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.7 M (USD)
in 2 rounds
-
Latest Funding Round
$23 M (USD), Series B
Aug 03, 2011
-
Investors
Boston Scientific
& 5 more
-
Employee Count
10
as on Dec 31, 2021
-
Acquired by
Boston Scientific
(Nov 08, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vessix Vascular
Vessix Vascular has successfully raised a total of $27.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $23 million completed in August 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $23.0M
-
First Round
First Round
(21 Oct 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2011 | Amount | Series B - Vessix Vascular | Valuation |
investors |
|
| Oct, 2010 | Amount | Series A - Vessix Vascular | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vessix Vascular
Vessix Vascular has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, Orbimed and Rothschild. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Stage-agnostic life sciences-focused VC firm investing in North America & Europe
|
Founded Year | Domain | Location | |
|
Risk capital is invested in growth companies in Western Norway.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vessix Vascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vessix Vascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vessix Vascular Comparisons
Competitors of Vessix Vascular
Vessix Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ReCor Medical, Ablative Solutions, Brattea, Kona Medical and Autonomix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ultrasound-based renal denervation is applied for hypertension treatment.
|
|
| domain | founded_year | HQ Location |
A catheter-based renal denervation system for hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
Developer of a medical device for the treatment of hypertension
|
|
| domain | founded_year | HQ Location |
Provides ultrasound-based renal denervation solutions for hypertension treatment.
|
|
| domain | founded_year | HQ Location |
Minimally invasive neural monitoring and treatment devices are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Vessix Vascular
When was Vessix Vascular founded?
Vessix Vascular was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Where is Vessix Vascular located?
Vessix Vascular is headquartered in Laguna Hills, United States. It is registered at Laguna Hills, California, United States.
Is Vessix Vascular a funded company?
Vessix Vascular is a funded company, having raised a total of $27.7M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.7M, raised on Oct 21, 2010.
How many employees does Vessix Vascular have?
As of Dec 31, 2021, the latest employee count at Vessix Vascular is 10.
What does Vessix Vascular do?
Vessix Vascular was established in 2003 in Laguna Hills, United States, within the medical device sector. Catheter-based systems for hypertension treatment are developed and manufactured. The ZCath System, featuring a low-pressure angioplasty catheter with radiofrequency electrodes, is utilized for endovascular procedures. Radiofrequency balloon catheters for renal denervation are also produced to manage hypertension. Operations center on thermoplasty applications for peripheral artery and vein occlusions.
Who are the top competitors of Vessix Vascular?
Vessix Vascular's top competitors include ReCor Medical, Autonomix and Ablative Solutions.
Who are Vessix Vascular's investors?
Vessix Vascular has 6 investors. Key investors include Boston Scientific, Orbimed, Rothschild, NeoMed, and Fjord Invest.